Long-Term Use of Dual Antiplatelet Therapy For The Secondary Prevention of Atherothrombotic Events: Meta-analysis of Randomized Controlled Trials

摘要

BackgroundThe potential benefit of long-term dual antiplatelet therapy (DAPT) for secondary prevention of atherothrombotic events is unclear. Data from different randomized controlled trials (RCT) using different agents in different subgroups showed inconsistent results.